Legal Representation
Attorney
Paul C. Llewellyn
USPTO Deadlines
Next Deadline
2187 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-29)
Due Date
July 29, 2031
Grace Period Ends
January 29, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 29, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 29, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 16, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jul 7, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 5, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 2, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 2, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 17, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 16, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 14, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 8, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jun 12, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 12, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 12, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 29, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 29, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 29, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 30, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 28, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 28, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 28, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 6, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 6, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 12, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 17, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 17, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 27, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 14, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 13, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 11, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 11, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 11, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 11, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 11, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 8, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 8, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 8, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 30, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical drug development services; biomedical research services; pharmaceutical research services; consulting services in the fields of biotechnology and pharmaceutical research and development; providing information in the fields of biotechnology and pharmaceutical research; providing medical and scientific information in the field of biotechnology and pharmaceutical research and development
First Use Anywhere:
20200500
First Use in Commerce:
20200500
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"